Emory begins enrolment for BioCardia’s trial of ischemic heart failure therapy

Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial of CardiAMP Cell Therapy Product in treating ischemic heart failure.